Company Category: M&A Strategy/Licensing/Investor Relations

Dasher Neuroscience Inc.

Dasher Neuroscience is dedicated to pioneering research in central nervous system (CNS) diseases. By integrating artificial intelligence (AI) technology, Dasher Neuroscience aims to drive groundbreaking advances, offering innovative treatment options for patients worldwide.

Read More

Celltrion, Inc.

A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business. | Celltrion is a leading global biopharmaceutical company dedicated to improving the health and well-being of patients. We have presented a new paradigm to the global biologics market with the launch of the world’s first monoclonal antibody biosimilar. Celltrion will continue to pursue its goal in promoting the health and well-being of patients.

Read More

BrevisRefero

BrevisRefero, in partnership with the educational platform BrickMMO, is pleased to be showcasing an ‘Interactive Biologics CDMO Facility Constructed Exclusively from LEGO(R) Bricks’ at it’s booth (1313) at BIO2024. Join us at our booth for an immersive and educational look at the biologics manufacturing like never before! BrevisRefero is a collection of biologics professionals who share a common goal – to improve and support the management of biologics programs from concept to development, GMP manufacturing and into clinical trials for the benefit of patient and sponsor alike. Pulling from more than 100 years of collective technical biotech consulting experience, we work closely with our clients to develop realistic technical and strategic solutions to support the execution and delivery of biologics programs. BrevisRefero also hosts an RFP outsource management platform called RFP>Navigator(R) that simplifies and accelerates Sponsor’s selection of their CDMO partners. | BrevisRefero Corporation is a team of biopharma professionals with a collective 100 years of biotechnology experience who assist Innovator companies to develop and manufacture their large-molecule biologics for clinical trials and commercial markets. The company assists Innovators by partnering with them at the target molecule post discovery stage and walking with them through their product development journey. Ground-level assistive support is provided in all technical aspects of drug development – from analytical methods and process development, through to scale-up and GMP manufacturing, and every aspect in between supporting their CMC program. Utilizing the deep-seated technical experience of BrevisRefero’s full-time consultants, we have developed innovative world-class online technology tools. Our award-winning commercial product RFP>Navigator®as well as our newly developed BioBudget Champion(TM) tool help propel the biopharma industry forward. Whether it is through our technical knowledge, or its application, BrevisRefero is driven to enable Innovators to succeed in their product development journey.

Read More

BioLabs

BioLabs is on a mission to enable innovation worldwide. The BioLabs innovation support platform pairs fully supported and equipped co-working wet lab facilities and office space with the international network of experts, mentors, and potential collaborators needed to accelerate cutting-edge life science innovation. Located in key biotech hubs in across the US, Europe, and Japan, BioLabs is the premier growth partner for life science entrepreneurs globally. | Life Science innovation support platform offering a global network fully equipped and supported coworking wet lab & office facilities, entrepreneur support services, access to a worldwide network of potential collaborators and capital partners. | BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency.

Read More

BIO Business Solutions®

BIO Business Solutions is the largest cost-savings purchasing program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life sciences companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, regulatory services, HR and much more. BIO helped 4,700 life science companies save over $705 million last year alone. | BIO Business Solutions is the largest cost-savings program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life science companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, cleanroom services, HR and much more. Every year, BIO helps nearly 5,000 companies save over $700 million. | BIO Business Solutions is the largest cost savings program for the life sciences industry, operated by BIO. BIO Business Solutions negotiates significant volume-based discounts, favorable terms, and other benefits on products and services with industry leading suppliers on behalf of BIO members and the members of state and regional biotech associations. Learn more at bio.org/save.

Read More

Barrington James

Barrington James are an industry leading, global recruitment business that exclusively serves the Pharmaceutical, Biotechnology and Medical Device sectors. With offices all over the world and hundreds of specialists dedicated to sourcing exceptional talent, we have the capacity and capabilities to deliver world-class recruitment solutions to Life Science companies of all sizes.

Read More